Figure 1‑1: Patient Monitoring Equipment Market Share Ranking by Segment, U.S., 2023 (1 of 3) |
Figure 1‑2: Patient Monitoring Equipment Market Share Ranking by Segment, U.S., 2023 (2 of 3) |
Figure 1‑3: Patient Monitoring Equipment Market Share Ranking by Segment, U.S., 2023 (3 of 3) |
Figure 1‑4: Companies Researched in This Report, U.S., 2023 (1 of 3) |
Figure 1‑5: Companies Researched in this Report, U.S., 2023 (2 of 3) |
Figure 1‑6: Companies Researched in this Report, U.S., 2023 (3 of 3) |
Figure 1‑7: Factors Impacting the Patient Monitoring Equipment Market by Segment, U.S. (1 of 3) |
Figure 1‑8: Factors Impacting the Patient Monitoring Equipment Market by Segment, U.S. (2 of 3) |
Figure 1‑9: Factors Impacting the Patient Monitoring Equipment Market by Segment, U.S. (3 of 3) |
Figure 1‑10: Recent Events in the Patient Monitoring Equipment Market, U.S., 2020 – 2023 (1 of 3) |
Figure 1‑11: Recent Events in the Patient Monitoring Equipment Market, U.S., 2020 – 2023 (2 of 3) |
Figure 1‑12: Recent Events in the Patient Monitoring Equipment Market, U.S., 2020 – 2023 (3 of 3) |
Figure 1‑13: Patient Monitoring Equipment Procedures Covered |
Figure 1‑14: Procedure Codes Investigated |
Figure 1‑15: Patient Monitoring Equipment Markets Covered (1 of 6) |
Figure 1‑16: Patient Monitoring Equipment Markets Covered (2 of 6) |
Figure 1‑17: Patient Monitoring Equipment Markets Covered (3 of 6) |
Figure 1‑18: Patient Monitoring Equipment Markets Covered (4 of 6) |
Figure 1‑19: Patient Monitoring Equipment Markets Covered (5 of 6) |
Figure 1‑20: Patient Monitoring Equipment Markets Covered (6 of 6) |
Figure 1‑21: Key Report Updates |
Figure 1‑22: Version History |
Figure 2‑1: Patient Monitoring Equipment Market by Segment, Worst Case Scenario, U.S., 2020 – 2030 (US$M) (1 of 2) |
Figure 2‑2: Patient Monitoring Equipment Market by Segment, Worst Case Scenario, U.S., 2020 – 2030 (US$M) (2 of 2) |
Figure 2‑3: Patient Monitoring Equipment Market by Segment, Base Case Scenario, U.S., 2020 – 2030 (US$M) (1 of 2) |
Figure 2‑4: Patient Monitoring Equipment Market by Segment, Base Case Scenario, U.S., 2020 – 2030 (US$M) (2 of 2) |
Figure 2‑5: Patient Monitoring Equipment Market by Segment, Best Case Scenario, U.S., 2020 – 2030 (US$M) (1 of 2) |
Figure 2‑6: Patient Monitoring Equipment Market by Segment, Best Case Scenario, U.S., 2020 – 2030 (US$M) (2 of 2) |
Figure 3‑1: Multi-Parameter Vital Signs Monitoring Products by Company |
Figure 3‑2: Wireless Ambulatory Telemetry Monitoring Products by Company |
Figure 3‑3: Remote Patient Monitoring Market by Company (1 of 2) |
Figure 3‑4: Remote Patient Monitoring Market by Company (2 of 2) |
Figure 3‑5: Intracranial Pressure (ICP) Monitoring Products by Company (1 of 2) |
Figure 3‑6: Intracranial Pressure (ICP) Monitoring Products by Company (2 of 2) |
Figure 3‑7: Electromyogram Monitoring Products by Company (1 of 2) |
Figure 3‑8: Electromyogram Monitoring Products by Company (2 of 2) |
Figure 3‑9: Electroencephalogram Monitoring (EEG) Products by Company (1 of 2) |
Figure 3‑10: Electroencephalogram Monitoring (EEG) Products by Company (2 of 2) |
Figure 3‑11: Cerebral Oximetry Monitoring Products by Company (1 of 2) |
Figure 3‑12: Cerebral Oximetry Monitoring Products by Company (2 of 2) |
Figure 3‑13: Fetal and Neonatal Monitoring Products by Company |
Figure 3‑14: Pulse Oximetry Monitoring Products by Company |
Figure 3‑15: Cardiac Output Monitoring Products by Company |
Figure 3‑16: Blood Pressure Monitoring Products by Company (1 of 3) |
Figure 3‑17: Blood Pressure Monitoring Products by Company (2 of 3) |
Figure 3‑18: Blood Pressure Monitoring Products by Company (3 of 3) |
Figure 3‑19: Electrocardiogram Monitoring Products by Company |
Figure 3‑20: Electrocardiogram Monitoring Products by Company |
Figure 3‑21: Temperature Management Market by Company (1 of 2) |
Figure 3‑22: Temperature Management Market by Company (2 of 2) |
Figure 3‑23: Intraoperative Neurophysiology Monitoring Market by Company |
Figure 3‑24: Train of Four Monitoring (TOF) Market by Company |
Figure 3‑25: Standalone Capnography Monitor Market by Company |
Figure 3‑26: Class 2 Device Recall EarlyVue VS30 Vitals Monitor |
Figure 3‑27: Class 2 Device Recall Welch Allyn Connex Spot Monitor |
Figure 3‑28: Class 2 Device Recall Philips EARLYVUE VS30 VITAL SIGNS MONITOR |
Figure 3‑29: Class 2 Device Recall Mindray BeneVision Distributed Monitoring System (DMS) |
Figure 3‑30: Class 2 Device Recall CARESCAPE ONE |
Figure 3‑31: Class 2 Device Recall Spacelabs Healthcare Xhibit Central Station (96102) |
Figure 3‑32: Class 2 Device Recall DIRECT SUPPLY Attendant VITAL SIGNS MONITOR |
Figure 3‑33: Class 2 Device Recall Expression MR400 MRI Patient Monitoring System |
Figure 3‑34: Class 2 Device Recall Rosebud Vital Signs Monitor |
Figure 3‑35: Class 2 Device Recall SureSigns VS3 NBP |
Figure 3‑36: Class 2 Device Recall Xhibit Telemetry Receiver, Model: 96280 |
Figure 3‑37: Class 2 Device Recall Drager Infinity CentralStation |
Figure 3‑38: Class 2 Device Recall WMTS Telemetry Receiver, Multiple Patient Receiver |
Figure 3‑39: Class 2 Device Recall Infinity M300 |
Figure 3‑40: Class 2 Device Recall ApexPro Telemetry System |
Figure 3‑41: Class 2 Device Recall ApexPro Telemetry Server System |
Figure 3‑42: Class 2 Device Recall IntelliVue MX40 Patient Monitor |
Figure 3‑43: Class 2 Device Recall Spacelabs Healthcare Xhibit Telemetry Receiver, Model 96280, software version 1.1 |
Figure 3‑44: Class 2 Device Recall Boston Scientific Emblem |
Figure 3‑45: Class 2 Device Recall CardioMEMS |
Figure 3‑46: Class 2 Device Recall LATITUDE" NXT Remote Patient Management System |
Figure 3‑47: Class 2 Device Recall EMBLEM SICD |
Figure 3‑48: Class 2 Device Recall CareLink SmartSync Device Manager |
Figure 3‑49: Class 1 Device Recall Assurity Pacemakers |
Figure 3‑50: Class 1 Device Recall St. Jude Endurity Pacemakers |
Figure 3‑51: Class 2 Device Recall EMBLEM |
Figure 3‑52: Class 2 Device Recall EMBLEM |
Figure 3‑53: Class 2 Device Recall LATITUDE |
Figure 3‑54: Class 2 Device Recall LATITUDE Programming System |
Figure 3‑55: Class 2 Device Recall CareLink 2090 Programmer System |
Figure 3‑56: Class 2 Device Recall Edwards TruWave/VAMP Kit |
Figure 3‑57: Class 2 Device Recall CereLink ICP Monitor |
Figure 3‑58: Class 2 Device Recall VentriClear |
Figure 3‑59: Class 2 Device Recall CADWELL |
Figure 3‑60: Class 2 Device Recall Ultraview SL (UVSL) Command Module |
Figure 3‑61: Class 2 Device Recall CARESCAPE ONE |
Figure 3‑62: Class 2 Device Recall IntelliVue MX800 |
Figure 3‑63: Class 2 Device Recall IntelliVue MX800 |
Figure 3‑64: Class 2 Device Recall CARESCAPE Patient Data Module |
Figure 3‑65: Class 2 Device Recall Pacific Medical GE Corometrics Nautilus Toco Transducer |
Figure 3‑66: Class 2 Device Recall |
Figure 3‑67: Class 3 Device Recall Starling |
Figure 3‑68: Class 2 Device Recall Cogent Hemodynamic Monitoring System |
Figure 3‑69: Class 2 Device Recall Cogent Hemodynamic Monitoring System |
Figure 3‑70: Class 2 Device Recall Cogent" Hemodynamic Monitoring System |
Figure 3‑71: Class 2 Device Recall Cogent" Hemodynamic Monitoring System |
Figure 3‑72: Class 2 Device Recall PulsioFlex Monitor |
Figure 3‑73: Class 1 Device Recall EV1000 Clinical Platform |
Figure 3‑74: Class 2 Device Recall ProBP 3400 Digital Blood Pressure Device |
Figure 3‑75: Class 2 Device Recall Ambulatory Blood Pressure Monitor |
Figure 3‑76: Class 2 Device Recall Blood Pressure Cuffs Disposable, Neonate |
Figure 3‑77: Class 2 Device Recall Baxter Epiphany |
Figure 3‑78: Class 2 Device Recall Draeger Infinity M300 |
Figure 3‑79: Class 2 Device Recall 3M Red Dot |
Figure 3‑80: Class 2 Device Recall ELI, Burdick and McKesson brand 280 Resting Electrocardiographs |
Figure 3‑81: Class 2 Device Recall MAC VU360, Electrocardiograph |
Figure 3‑82: Class 2 Device Recall Novaplus |
Figure 3‑83: Class 2 Device Recall ELI 10, ELI 350, ELI 150c, ELI 250c, ELI 230, ELI 280, |
Figure 3‑84: Class 1 Device Recall NORMOFLO |
Figure 3‑85: Class 2 Device Recall CritiCool |
Figure 3‑86: Class 2 Device Recall NormOTemp Hyperthermia System |
Figure 3‑87: Class 2 Device Recall Blanketrol II Model 233 HyperHypothermia System and CoolBlue Model 2501 HyperHypothermia System |
Figure 3‑88: Class 2 Device Recall Blanketrol II HyperHypothermia System, 222S |
Figure 3‑89: Class 2 Device Recall NIM Vital 4.0 Patient Interface |
Figure 3‑90: Class 2 Device Recall NIM Vital |
Figure 3‑91: Image-based Remote Monitoring in Cardiac Surgery Patients (FORSEE-3) |
Figure 3‑92: Validation of a Vital Signs Monitoring Wristband (MULTI-VITAL) |
Figure 3‑93: A Single Center Study to Demonstrate the Safety and Performance of Lifelight® First Software Application |
Figure 3‑94: The COSMOS Trial. A Pilot Study A Pilot Study |
Figure 3‑95: NIBP Validation Study |
Figure 3‑96: Dexcom CGM in Long-term Care |
Figure 3‑97: Detection of Atrial Fibrillation after Cardiac Surgery |
Figure 3‑98: Feasibility and Success Trial of Remote Patient Monitoring in Heart Failure |
Figure 3‑99: FreeStyle Libre 2 Discharge Trial |
Figure 3‑100: Enhanced Pulmonary Rehabilitation With Digital Remote Home Monitoring |
Figure 3‑101: Remote Monitoring of Multiple Indicators of Heart Failure |
Figure 3‑102: Impact of the CareLink Express Remote Monitoring System on Early Detection of Atrial Fibrillation |
Figure 3‑103: Remote Patient Monitoring in Pediatric Obesity |
Figure 3‑104: A Pilot Study of Hypertension Management Using Remote Patient Monitoring |
Figure 3‑105: Intracranial Pressure Monitoring in Moderate Traumatic Brain Injury |
Figure 3‑106: Intracranial Pressure in Intensive Care (ICU) (SynapseICU) |
Figure 3‑107: Validation of Non-Invasive Intracranial Pressure (ICP) Monitoring Device |
Figure 3‑108: Informative of Surface Electromyography and Prognostic Factors in Assessing the Recovery of Balance and Gait after Stroke |
Figure 3‑109: Association of Perioperative Electroencephalography Spectral Analysis with Postoperative Complications |
Figure 3‑110: 48-Hour Ambulatory EEG Monitoring in Early Onset Alzheimer's Disease |
Figure 3‑111: Bispectral-Electroencephalography (EEG) in First Time Hemodialysis |
Figure 3‑112: Wearable Sensor for Responsive DBS for ET |
Figure 3‑113: Investigating Cerebral Oxygenation in the Newborn |
Figure 3‑114: Accuracy Performance Verification of the INVOS™ System in Pediatrics |
Figure 3‑115: Cerebral Oxygen Saturation Monitoring in Cardiac Surgery (COSMICS) |
Figure 3‑116: Role of Cerebral Oximetry in Reducing Postoperative End Organ Dysfunction/Failure after Complex Non-Cardiac Surgery |
Figure 3‑117: Validation of the O3 Regional Somatic Tissue Oxygenation Monitor |
Figure 3‑118: Continuous Vital Sign Monitoring in Newborns |
Figure 3‑119: Continuous Glucose Monitoring in At-Risk Newborns |
Figure 3‑120: Preliminary Study to the Conception of a Non-invasive Neonatal Monitoring System With Development of a Database |
Figure 3‑121: Transcutaneous Carbon Dioxide Monitoring in Neonates Receiving Therapeutic Hypothermia for Neonatal Encephalopathy |
Figure 3‑122: U-TruSignal SpO2 Testing in Neonates |
Figure 3‑123: Pulse Oximetry Accuracy by Skin Color |
Figure 3‑124: Neonatal Pulse Oximetry Disparities due to Skin Pigmentation |
Figure 3‑125: Philps FAST2022 picoSAT Pulse Oximetry Desaturation Study |
Figure 3‑126: Oxygen Saturation Measurement with Pulse Oximetry and with Smart Phones and Smart Wearable |
Figure 3‑127: SpO2 Accuracy Validation of the OxySoft Sensor via Reference CO-Oximetry Motion Study |
Figure 3‑128: Home Pulse Oximeter Use in Patients with COVID-19 |
Figure 3‑129: Feasibility and Performance Evaluation of INVSENSOR00024 |
Figure 3‑130: BiOSENCY BORA Band SpO2 Validation Study |
Figure 3‑131: Feasibility and Performance Evaluation for INVSENSOR00024 |
Figure 3‑132: Validation of CardioQ Versus PiCCO in Children |
Figure 3‑133: Pediatric Cardiac Output Monitoring Observational Study (POGO) |
Figure 3‑134: Association between the Use of Pulmonary Artery Catheter and Clinical Outcomes after Liver Transplantation |
Figure 3‑135: Non-invasive Continuous Cardiac Output Monitoring in Preterm Infants Study |
Figure 3‑136: ClearSight System CHN Study |
Figure 3‑137: Team-Based Home Blood Pressure Monitoring |
Figure 3‑138: Comparison of Non-invasive and Invasive Blood Pressure Monitors |
Figure 3‑139: App-Based Remote Blood Pressure Monitoring |
Figure 3‑140: A Study of Continuous Blood Pressure Monitoring in Healthy Participants |
Figure 3‑141: Noninvasive Continuous Blood Pressure Monitoring for Cesarean Delivery |
Figure 3‑142: A Pilot Study of Hypertension Management Using Remote Patient Monitoring |
Figure 3‑143: Validation of Wrist Type Oscillometric Blood Pressure Monitorings |
Figure 3‑144: Hypertension Control and Remote Blood Pressure Monitoring |
Figure 3‑145: Validation of Noninvasive Blood Pressure Device |
Figure 3‑146: Clinical Validation of the Electrocardiogram Measurement |
Figure 3‑147: The Value of Wearable Electrocardiogram in the Diagnosis of Coronary Artery Disease |
Figure 3‑148: Electrocardiogram Clinical Validation Study |
Figure 3‑149: Heated Humidification System Breathing Circuit for Maintenance of Body Temperature in Pediatric Patients |
Figure 3‑150: Determination of Core Body Temperature in Parturient Warmed with Upper or Underbody Forced Air Cover (Bair Hugger) |
Figure 3‑151: The Effect of Intraoperative Forced Air Warmer Use, on Postoperative Nausea and Vomiting |
Figure 3‑152: Efficacy of Blanketrol III and Arctic Sun in Cooling Non-shivering Humans |
Figure 3‑153: Comparison of Electric Heating Pad Versus Forced-Air Warming to Prevent Inadvertent Perioperative Hypothermia |
Figure 3‑154: Two Warming Methods in Knee Arthroplasty |
Figure 3‑155: Comparison Neuromuscular Blockade Monitors |
Figure 3‑156: Train-of-four Monitoring Using the Tetragraph |
Figure 3‑157: Minimum Current for Train-of-Four Monitoring |
Figure 4‑1: Patient Monitoring Equipment Market by Segment, U.S., 2020 – 2030 (US$M) (1 of 2) |
Figure 4‑2: Patient Monitoring Equipment Market by Segment, U.S., 2020 – 2030 (US$M) (2 of 2) |
Figure 4‑3: Leading Competitors, Patient Monitoring Equipment Market, U.S., 2023 (1 of 4) |
Figure 4‑4: Leading Competitors, Patient Monitoring Equipment Market, U.S., 2023 (2 of 4) |
Figure 4‑5: Leading Competitors, Patient Monitoring Equipment Market, U.S., 2023 (3 of 4) |
Figure 4‑6: Leading Competitors, Patient Monitoring Equipment Market, U.S., 2023 (4 of 4) |
Figure 4‑7: SWOT Analysis, Baxter |
Figure 4‑8: SWOT Analysis, Becton Dickinson |
Figure 4‑9: SWOT Analysis, Edwards Lifesciences |
Figure 4‑10: SWOT Analysis, GE HealthCare |
Figure 4‑11: SWOT Analysis, Honeywell Life Sciences |
Figure 4‑12: SWOT Analysis, Masimo |
Figure 4‑13: SWOT Analysis, Medtronic |
Figure 4‑14: SWOT Analysis, Natus Medical |
Figure 4‑15: SWOT Analysis, Nihon Kohden |
Figure 4‑16: SWOT Analysis, Philips Healthcare |
Figure 5‑1: Procedure Codes Investigated, U.S., 2023 |
Figure 5‑2: Patient Monitoring Equipment Procedures by Segment, U.S., 2020 – 2030 |
Figure 5‑3: Electromyography (EMG) Procedures by Setting, U.S., 2020 – 2030 |
Figure 5‑4: Electroencephalography (EEG) Procedures by Setting, U.S., 2020 – 2030 |
Figure 5‑5: Cerebral Oximetry Procedures by Setting, U.S., 2020 – 2030 |
Figure 5‑6: Electrocardiogram (ECG) Procedures by Setting, U.S., 2020 – 2030 |
Figure 6‑1: Multi-Parameter Vital Signs Monitoring Market by Segment, U.S., 2020 – 2030 (US$M) |
Figure 6‑2: Low-Acuity Vital Signs Monitoring Market by Segment, U.S., 2020 – 2030 (US$M) |
Figure 6‑3: Total Low-Acuity Vital Signs Monitoring Market, U.S., 2020 – 2030 |
Figure 6‑4: Hospital Low-Acuity Vital Signs Monitoring Market by Segment, U.S., 2020 – 2030 (US$M) |
Figure 6‑5: Total Hospital Low-Acuity Vital Signs Monitoring Market, U.S., 2020 – 2030 |
Figure 6‑6: Hospital Low-Acuity Bedside Monitor with ECG Waveforms Market, U.S., 2020 – 2030 |
Figure 6‑7: Hospital Low-Acuity Bedside Monitor without ECG Waveforms Market, U.S., 2020 – 2030 |
Figure 6‑8: Hospital Low-Acuity Spot-Check Monitor Market, U.S., 2020 – 2030 |
Figure 6‑9: Alternate Care Low-Acuity Vital Signs Monitoring Market by Segment, U.S., 2020 – 2030 (US$M) |
Figure 6‑10: Total Alternate Care Low-Acuity Vital Signs Monitoring Market, U.S., 2020 – 2030 |
Figure 6‑11: Alternate Care Low-Acuity Bedside Monitor with ECG Waveforms Market, U.S., 2020 – 2030 |
Figure 6‑12: Alternate Care Low-Acuity Bedside Monitor without ECG Waveforms Market, U.S., 2020 – 2030 |
Figure 6‑13: Alternate Care Low-Acuity Spot-Check Monitor Market, U.S., 2020 – 2030 |
Figure 6‑14: Mid-Acuity Vital Signs Monitoring Market by Segment, U.S., 2020 – 2030 (US$M) |
Figure 6‑15: Total Mid-Acuity Vital Signs Monitoring Market, U.S., 2020 – 2030 |
Figure 6‑16: Hospital Mid-Acuity Vital Signs Monitoring Market, U.S., 2020 – 2030 |
Figure 6‑17: Alternate Care Mid-Acuity Vital Signs Monitoring Market, U.S., 2020 – 2030 |
Figure 6‑18: High-Acuity Vital Signs Monitoring Market by Segment, U.S., 2020 – 2030 (US$M) |
Figure 6‑19: Total High-Acuity Vital Signs Monitoring Market, U.S., 2020 – 2030 |
Figure 6‑20: Hospital High-Acuity Vital Signs Monitoring Market, U.S., 2020 – 2030 |
Figure 6‑21: Alternate Care High-Acuity Vital Signs Monitoring Market, U.S., 2020 – 2030 |
Figure 6‑22: Central Station Monitoring Market by Segment, U.S., 2020 – 2030 (US$M) |
Figure 6‑23: Low-Acuity Central Station Monitoring Market, U.S., 2020 – 2030 |
Figure 6‑24: Mid-Acuity Central Station Monitoring Market, U.S., 2020 – 2030 |
Figure 6‑25: High-Acuity Central Station Monitoring Market, U.S., 2020 – 2030 |
Figure 6‑26: Leading Competitors, Multi-Parameter Vital Signs Monitoring Market, U.S., 2023 |
Figure 7‑1: Wireless Ambulatory Telemetry Monitoring Market by Segment, U.S., 2020 – 2030 (US$M) |
Figure 7‑2: Patient-Worn Monitor Market by Segment, U.S., 2020 – 2030 (US$M) |
Figure 7‑3: Total Patient-Worn Monitor Market, U.S., 2020 – 2030 |
Figure 7‑4: Hospital Patient-Worn Monitor Market, U.S., 2020 – 2030 |
Figure 7‑5: Alternate Patient-Worn Monitor Market, U.S., 2020 – 2030 |
Figure 7‑6: Wireless Ambulatory Telemetry Central Station Market, U.S., 2020 – 2030 |
Figure 7‑7: Leading Competitors, Wireless Ambulatory Telemetry Monitoring Market, U.S., 2023 |
Figure 8‑1: Remote Patient Monitoring Market by Segment, U.S., 2020 – 2030 (US$M) |
Figure 8‑2: Disease Conditions Management Remote Patient Monitoring Market by Segment, U.S., 2020 – 2030 (US$M) |
Figure 8‑3: Purchased Remote Patient Monitoring for Disease Conditions Management Market, U.S., 2020 – 2030 |
Figure 8‑4: Leased Remote Patient Monitoring for Disease Conditions Management Market, U.S., 2020 – 2030 |
Figure 8‑5: Cardiac Implantable Electric Device Remote Patient Monitoring Market, U.S., 2020 – 2030 |
Figure 8‑6: Leading Competitors, Remote Patient Monitoring Market, U.S., 2023 |
Figure 9‑1: Intracranial Pressure Monitoring Market by Segment, U.S., 2020 – 2030 (US$M) |
Figure 9‑2: ICP Transducer System Market by Segment, U.S., 2020 – 2030 (US$M) |
Figure 9‑3: Total ICP Transducer System Market, U.S., 2020 – 2030 |
Figure 9‑4: Internal ICP Transducer System Market, U.S., 2020 – 2030 |
Figure 9‑5: External ICP Transducer System Market, U.S., 2020 – 2030 |
Figure 9‑6: ICP Drainage Device Market, U.S., 2020 – 2030 |
Figure 9‑7: Advanced ICP Monitoring Market by Segment, U.S., 2020 – 2030 (US$M) |
Figure 9‑8: Advanced ICP Monitor Market, U.S., 2020 – 2030 |
Figure 9‑9: Monitor with Tissue Oxygen Saturation Market, U.S., 2020 – 2030 |
Figure 9‑10: Advanced ICP Sensor Market, U.S., 2020 – 2030 |
Figure 9‑11: Universal ICP Disposables Market by Segment, U.S., 2020 – 2030 (US$M) |
Figure 9‑12: Universal ICP Cranial Access Kit Market, U.S., 2020 – 2030 |
Figure 9‑13: Total Universal ICP Catheter Market, U.S., 2020 – 2030 |
Figure 9‑14: Universal ICP Catheter Market by Catheter Type, U.S., 2017 – 2027 |
Figure 9‑15: Standard ICP Catheter Market, U.S., 2020 – 2030 |
Figure 9‑16: Antimicrobial ICP Catheter Market, U.S., 2020 – 2030 |
Figure 9‑17: Universal ICP Catheter Market by Temperature Monitoring, U.S., 2017 – 2027 |
Figure 9‑18: Conventional ICP Catheter Market, U.S., 2020 – 2030 |
Figure 9‑19: Temperature Monitoring ICP Catheter Market, U.S., 2020 – 2030 |
Figure 9‑20: Leading Competitors, Intracranial Pressure Monitoring Market, U.S., 2023 |
Figure 10‑1: Electromyogram Monitoring Market by Segment, U.S., 2020 – 2030 (US$M) |
Figure 10‑2: EMG Monitor Market by Setting, U.S., 2020 – 2030 (US$M) |
Figure 10‑3: Total EMG Monitor Market, U.S., 2020 – 2030 |
Figure 10‑4: Hospital EMG Monitor Market, U.S., 2020 – 2030 |
Figure 10‑5: Alternate Care EMG Monitor Market, U.S., 2020 – 2030 |
Figure 10‑6: Total EMG Consumables Market, U.S., 2020 – 2030 |
Figure 10‑7: EMG Consumables Market by Device Type, U.S., 2020 – 2030 (US$M) |
Figure 10‑8: EMG Concentric Needle Market, U.S., 2020 – 2030 |
Figure 10‑9: EMG Monopolar Needle Market, U.S., 2020 – 2030 |
Figure 10‑10: EMG Surface Electrode Market, U.S., 2020 – 2030 |
Figure 10‑11: EMG Consumables Units Sold by Setting, U.S., 2020 – 2030 |
Figure 10‑12: Leading Competitors, Electromyogram Monitoring Market, U.S., 2023 |
Figure 11‑1: EEG Wave Indicators of Physiological State |
Figure 11‑2: Electroencephalogram Monitoring Market by Segment, U.S., 2020 – 2030 (US$M) |
Figure 11‑3: Diagnostic EEG Market by Segment, U.S., 2020 – 2030 (US$M) |
Figure 11‑4: Clinical EEG Monitoring Market by Segment, U.S., 2020 – 2030 (US$M) |
Figure 11‑5: Total Clinical EEG Monitoring Market, U.S., 2020 – 2030 |
Figure 11‑6: Hospital Clinical EEG Monitoring Market, U.S., 2020 – 2030 |
Figure 11‑7: Alternate Care Clinical EEG Monitoring Market, U.S., 2020 – 2030 |
Figure 11‑8: Long-Term EEG Monitoring Market, U.S., 2020 – 2030 |
Figure 11‑9: ICU EEG Monitoring Market, U.S., 2020 – 2030 |
Figure 11‑10: Total EEG Electrode Market, U.S., 2020 – 2030 |
Figure 11‑11: EEG Electrode Market by Device Type, U.S., 2020 – 2030 (US$M) |
Figure 11‑12: Non-MRI Conditional EEG Electrode Market by Segment, U.S., 2020 – 2030 (US$M) |
Figure 11‑13: Total Non-MRI Conditional EEG Electrode Market, U.S., 2020 – 2030 |
Figure 11‑14: Disposable Non-MRI Conditional EEG Electrode Market, U.S., 2020 – 2030 |
Figure 11‑15: Reusable Non-MRI Conditional EEG Electrode Market, U.S., 2020 – 2030 |
Figure 11‑16: MRI Conditional EEG Electrode Market, U.S., 2020 – 2030 |
Figure 11‑17: EEG Electrode Market by Setting, U.S., 2020 – 2030 (US$M) |
Figure 11‑18: Hospital Inpatient EEG Electrode Market, U.S., 2020 – 2030 |
Figure 11‑19: Hospital Outpatient EEG Electrode Market, U.S., 2020 – 2030 |
Figure 11‑20: Office EEG Electrode Market, U.S., 2020 – 2030 |
Figure 11‑21: EEG Cap Market by Segment, U.S., 2020 – 2030 (US$M) |
Figure 11‑22: Total EEG Cap Market, U.S., 2020 – 2030 |
Figure 11‑23: Pediatric EEG Cap Market, U.S., 2020 – 2030 |
Figure 11‑24: Adult EEG Cap Market, U.S., 2020 – 2030 |
Figure 11‑25: Depth of Anesthesia EEG Market by Segment, U.S., 2020 – 2030 (US$M) |
Figure 11‑26: Standalone Module Market, U.S., 2020 – 2030 |
Figure 11‑27: OEM Module Market, U.S., 2020 – 2030 |
Figure 11‑28: Sensor Market by Segment, U.S., 2020 – 2030 (US$M) |
Figure 11‑29: Total Sensor Market, U.S., 2020 – 2030 |
Figure 11‑30: Pediatric Sensor Market, U.S., 2020 – 2030 |
Figure 11‑31: Adult Sensor Market, U.S., 2020 – 2030 |
Figure 11‑32: Rapid EEG Market by Segment, U.S., 2020 – 2030 (US$M) |
Figure 11‑33: Rapid EEG Monitoring Market, U.S., 2020 – 2030 |
Figure 11‑34: Rapid EEG Electrode Market, U.S., 2020 – 2030 |
Figure 11‑35: Leading Competitors, Electroencephalogram Monitoring Market, U.S., 2023 |
Figure 12‑1: Cerebral Oximetry Monitoring Market by Segment, U.S., 2020 – 2030 (US$M) |
Figure 12‑2: Cerebral Oximetry Monitor Market by Segment, U.S., 2020 – 2030 (US$M) |
Figure 12‑3: Total Cerebral Oximetry Monitor Market, U.S., 2020 – 2030 |
Figure 12‑4: Hospital Cerebral Oximetry Monitor Market, U.S., 2020 – 2030 |
Figure 12‑5: Alternate Care Cerebral Oximetry Monitor Market, U.S., 2020 – 2030 |
Figure 12‑6: Total Cerebral Oximetry Sensor Market, U.S., 2020 – 2030 |
Figure 12‑7: Cerebral Oximetry Sensor Market by Patient Type, U.S., 2020 – 2030 (US$M) |
Figure 12‑8: Adult Cerebral Oximetry Sensor Market, U.S., 2020 – 2030 |
Figure 12‑9: Pediatric Cerebral Oximetry Sensor Market, U.S., 2020 – 2030 |
Figure 12‑10: Cerebral Oximetry Sensor Market by Setting, U.S., 2020 – 2030 (US$M) |
Figure 12‑11: Hospital Cerebral Oximetry Sensor Market, U.S., 2020 – 2030 |
Figure 12‑12: Alternate Care Cerebral Oximetry Sensor Market, U.S., 2020 – 2030 |
Figure 12‑13: Leading Competitors, Cerebral Oximetry Monitoring Market, U.S., 2023 |
Figure 13‑1: Fetal and Neonatal Monitoring Market by Segment, U.S., 2020 – 2030 (US$M) |
Figure 13‑2: Fetal Monitoring Market, U.S., 2020 – 2030 |
Figure 13‑3: Neonatal Monitoring Market by Segment, U.S., 2020 – 2030 (US$M) |
Figure 13‑4: Total Neonatal Monitoring Market, U.S., 2020 – 2030 |
Figure 13‑5: Hospital Neonatal Monitoring Market, U.S., 2020 – 2030 |
Figure 13‑6: Alternate Care Neonatal Monitoring Market, U.S., 2020 – 2030 |
Figure 13‑7: Leading Competitors, Fetal and Neonatal Monitoring Market, U.S., 2023 |
Figure 14‑1: Pulse Oximetry Monitoring Market by Segment, U.S., 2020 – 2030 (US$M) |
Figure 14‑2: Hospital Pulse Oximetry Monitoring Market by Segment, U.S., 2020 – 2030 (US$M) |
Figure 14‑3: Total Hospital Pulse Oximetry Sensor Market, U.S., 2020 – 2030 |
Figure 14‑4: Hospital Pulse Oximetry Sensor Market by Device Type, U.S., 2020 – 2030 (US$M) |
Figure 14‑5: Disposable Hospital Pulse Oximetry Sensor Market, U.S., 2020 – 2030 |
Figure 14‑6: Reusable Hospital Pulse Oximetry Sensor Market, U.S., 2020 – 2030 |
Figure 14‑7: Hospital Pulse Oximetry Sensor Market by Patient Type, U.S., 2020 – 2030 (US$M) |
Figure 14‑8: Pediatric Hospital Pulse Oximetry Sensor Market, U.S., 2020 – 2030 |
Figure 14‑9: Adult Hospital Pulse Oximetry Sensor Market, U.S., 2020 – 2030 |
Figure 14‑10: Hospital Pulse Oximetry Monitor Market by Segment, U.S., 2020 – 2030 (US$M) |
Figure 14‑11: Total Hospital Pulse Oximetry Monitor Market, U.S., 2020 – 2030 |
Figure 14‑12: Bedside Hospital Pulse Oximetry Monitor Market, U.S., 2020 – 2030 |
Figure 14‑13: Handheld Hospital Pulse Oximetry Monitor Market, U.S., 2020 – 2030 |
Figure 14‑14: Fingertip Hospital Pulse Oximetry Monitor Market, U.S., 2020 – 2030 |
Figure 14‑15: Alternate Care Pulse Oximetry Monitoring Market by Segment, U.S., 2020 – 2030 (US$M) |
Figure 14‑16: Total Alternate Care Pulse Oximetry Sensor Market, U.S., 2020 – 2030 |
Figure 14‑17: Alternate Care Pulse Oximetry Sensor Market by Device Type, U.S., 2020 – 2030 (US$M) |
Figure 14‑18: Disposable Alternate Care Pulse Oximetry Sensor Market, U.S., 2020 – 2030 |
Figure 14‑19: Reusable Alternate Care Pulse Oximetry Sensor Market, U.S., 2020 – 2030 |
Figure 14‑20: Alternate Care Pulse Oximetry Sensor Market by Patient Type, U.S., 2020 – 2030 (US$M) |
Figure 14‑21: Pediatric Alternate Care Pulse Oximetry Sensor Market, U.S., 2020 – 2030 |
Figure 14‑22: Adult Alternate Care Pulse Oximetry Sensor Market, U.S., 2020 – 2030 |
Figure 14‑23: Alternate Care Pulse Oximetry Monitor Market by Segment, U.S., 2020 – 2030 (US$M) |
Figure 14‑24: Total Alternate Care Pulse Oximetry Monitor Market, U.S., 2020 – 2030 |
Figure 14‑25: Bedside Alternate Care Pulse Oximetry Monitor Market, U.S., 2020 – 2030 |
Figure 14‑26: Handheld Alternate Care Pulse Oximetry Monitor Market, U.S., 2020 – 2030 |
Figure 14‑27: Fingertip Alternate Care Pulse Oximetry Monitor Market, U.S., 2020 – 2030 |
Figure 14‑28: OEM Circuit Board Market, U.S., 2020 – 2030 |
Figure 14‑29: Leading Competitors, Pulse Oximetry Monitoring Market, U.S., 2023 |
Figure 15‑1: Cardiac Output Monitoring Market by Segment, U.S., 2020 – 2030 (US$M) |
Figure 15‑2: Pulmonary Artery Catheter Market by Segment, U.S., 2020 – 2030 (US$M) |
Figure 15‑3: Total Pulmonary Artery Catheter Market, U.S., 2020 – 2030 |
Figure 15‑4: Standard (Bolus) Thermodilution Pulmonary Artery Catheter Market, U.S., 2020 – 2030 |
Figure 15‑5: Specialty Pulmonary Artery Catheter Market, U.S., 2020 – 2030 |
Figure 15‑6: Minimally Invasive Cardiac Output Monitoring Market by Segment, U.S., 2020 – 2030 (US$M) |
Figure 15‑7: Minimally Invasive Cardiac Output Monitor Market, U.S., 2020 – 2030 |
Figure 15‑8: Minimally Invasive Cardiac Output Sensor Market, U.S., 2020 – 2030 |
Figure 15‑9: Non-Invasive Cardiac Output Monitoring Market by Segment, U.S., 2020 – 2030 (US$M) |
Figure 15‑10: Non-Invasive Cardiac Output Monitor Market, U.S., 2020 – 2030 |
Figure 15‑11: Non-Invasive Cardiac Output Sensor Market, U.S., 2020 – 2030 |
Figure 15‑12: Leading Competitors, Cardiac Output Monitoring Market, U.S., 2023 |
Figure 16‑1: Blood Pressure Monitoring Market by Segment, U.S., 2020 – 2030 (US$M) |
Figure 16‑2: Personal Blood Pressure Monitoring Market by Segment, U.S., 2020 – 2030 (US$M) |
Figure 16‑3: Total Personal Blood Pressure Monitoring Market, U.S., 2020 – 2030 |
Figure 16‑4: Digital Personal Blood Pressure Monitoring Market, U.S., 2020 – 2030 |
Figure 16‑5: Aneroid Personal Blood Pressure Monitoring Market, U.S., 2020 – 2030 |
Figure 16‑6: Professional Blood Pressure Monitoring Market by Segment, U.S., 2020 – 2030 (US$M) |
Figure 16‑7: Total Professional Blood Pressure Monitoring Market, U.S., 2020 – 2030 |
Figure 16‑8: Digital Professional Blood Pressure Monitoring Market, U.S., 2020 – 2030 |
Figure 16‑9: Aneroid Professional Blood Pressure Monitoring Market, U.S., 2020 – 2030 |
Figure 16‑10: Blood Pressure Cuff Market by Segment, U.S., 2020 – 2030 (US$M) |
Figure 16‑11: Total Blood Pressure Cuff Market, U.S., 2020 – 2030 |
Figure 16‑12: Reusable Blood Pressure Cuff Market, U.S., 2020 – 2030 |
Figure 16‑13: Disposable Blood Pressure Cuff Market, U.S., 2020 – 2030 |
Figure 16‑14: Leading Competitors, Blood Pressure Monitoring Market, U.S., 2023 |
Figure 17‑1: Electrocardiogram Monitoring Market by Segment, U.S., 2020 – 2030 (US$M) |
Figure 17‑2: ECG Monitor Market by Segment, U.S., 2020 – 2030 (US$M) |
Figure 17‑3: Resting Electrocardiogram Market by Segment, U.S., 2020 – 2030 (US$M) |
Figure 17‑4: Total Resting Electrocardiogram Market, U.S., 2020 – 2030 |
Figure 17‑5: Hospital-Based Resting Electrocardiogram Market, U.S., 2020 – 2030 |
Figure 17‑6: Office-Based Resting Electrocardiogram Market by Segment, U.S., 2020 – 2030 (US$M) |
Figure 17‑7: Total Office-Based Resting Electrocardiogram Market, U.S., 2020 – 2030 |
Figure 17‑8: Purpose Built Office-Based Resting Electrocardiogram Market, U.S., 2020 – 2030 |
Figure 17‑9: PC-Based Office-Based Resting Electrocardiogram Market, U.S., 2020 – 2030 |
Figure 17‑10: Stress Testing Electrocardiogram Market by Segment, U.S., 2020 – 2030 (US$M) |
Figure 17‑11: Total Stress Testing Electrocardiogram Market, U.S., 2020 – 2030 |
Figure 17‑12: Hospital-Based Stress Testing Electrocardiogram Market, U.S., 2020 – 2030 |
Figure 17‑13: Office-Based Stress Testing Electrocardiogram Market, U.S., 2020 – 2030 |
Figure 17‑14: Holter Monitoring Recorder Market by Segment, U.S., 2020 – 2030 (US$M) |
Figure 17‑15: Total Holter Monitoring Recorder Market, U.S., 2020 – 2030 |
Figure 17‑16: Hospital-Based Holter Monitoring Recorder Market, U.S., 2020 – 2030 |
Figure 17‑17: Office-Based Holter Monitoring Recorder Market, U.S., 2020 – 2030 |
Figure 17‑18: IDTF Holter Monitoring Recorder Market, U.S., 2020 – 2030 |
Figure 17‑19: Total ECG Electrode Market, U.S., 2020 – 2030 |
Figure 17‑20: ECG Electrode Market by Device Type, U.S., 2020 – 2030 (US$M) |
Figure 17‑21: Long-Term ECG Electrode Market, U.S., 2020 – 2030 |
Figure 17‑22: Resting ECG Electrode Market, U.S., 2020 – 2030 |
Figure 17‑23: Short-Term ECG Electrode Market, U.S., 2020 – 2030 |
Figure 17‑24: Stress Testing ECG Electrode Market, U.S., 2020 – 2030 |
Figure 17‑25: Neonatal ECG Electrode Market, U.S., 2020 – 2030 |
Figure 17‑26: ECG Electrode Market by Setting, U.S., 2020 – 2030 (US$M) |
Figure 17‑27: Hospital ECG Electrode Market, U.S., 2020 – 2030 |
Figure 17‑28: Clinic ECG Electrode Market, U.S., 2020 – 2030 |
Figure 17‑29: Prehospital ECG Electrode Market, U.S., 2020 – 2030 |
Figure 17‑30: Leading Competitors, Electrocardiogram Monitoring Market, U.S., 2023 |
Figure 18‑1: Temperature Management Market by Segment, U.S., 2020 – 2030 (US$M) |
Figure 18‑2: Surface-Pad Temperature Management Market by Segment, U.S., 2020 – 2030 (US$M) |
Figure 18‑3: Surface-Pad Temperature Management Machine Market, U.S., 2020 – 2030 |
Figure 18‑4: Surface-Pad Temperature Management Accessory Market, U.S., 2020 – 2030 |
Figure 18‑5: Intravascular Temperature Management Market by Segment, U.S., 2020 – 2030 (US$M) |
Figure 18‑6: Intravascular Temperature Management Machine Market, U.S., 2020 – 2030 |
Figure 18‑7: Intravascular Temperature Management Accessory Market, U.S., 2020 – 2030 |
Figure 18‑8: Forced-Air Warming Accessory Market, U.S., 2020 – 2030 |
Figure 18‑9: Leading Competitors, Temperature Management Market, U.S., 2023 |
Figure 19‑1: Intraoperative Neurophysiology Monitoring Market by Device Type, U.S., 2020 – 2030 (US$M) |
Figure 19‑2: Intraoperative Neurophysiology Monitoring System Market, U.S., 2020 – 2030 |
Figure 19‑3: Intraoperative Neurophysiology Monitoring Electrode Market, U.S., 2020 – 2030 |
Figure 19‑4: Leading Competitors, Intraoperative Neurophysiology Monitoring Market, U.S., 2023 |
Figure 20‑1: Standalone Capnography Monitoring Market by Segment, U.S., 2020 – 2030 (US$M) |
Figure 20‑2: Mainstream Capnography Monitoring Market, U.S., 2020 – 2030 |
Figure 20‑3: Sidestream Capnography Monitoring Market, U.S., 2020 – 2030 |
Figure 20‑4: Microstream Capnography Monitoring Market, U.S., 2020 – 2030 |
Figure 20‑5: Leading Competitors, Standalone Capnography Monitoring Market, U.S., 2023 |
Figure 21‑1: Train-of-Four Monitoring Market by Segment, U.S., 2020 – 2030 (US$M) |
Figure 21‑2: Train-of-Four Monitor Market, U.S., 2020 – 2030 |
Figure 21‑3: Leading Competitors, Train-of-Four Monitoring Market, U.S., 2023 |